Ramireddy Bommireddy

Assistant Professor

Emory University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ramireddy Bommireddy is an Assistant Professor at Emory University School of Medicine in the United States. His research focuses on the chemoprevention of head and neck cancer, immune responses in breast cancer, and innovative vaccine strategies against influenza and SARS-CoV-2. Recent publications reflect his work on tumor-intrinsic factors affecting immune infiltration and the development of tumor membrane-based immunotherapies.

Articles (7)

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

SAng Moo Kang

University of Georgia

UNITED STATES

View details

Periasamy Selvaraj

Professor

Emory University

UNITED STATES

View details

Sanghoon Han

Jeju National University College of Medicine and Graduate School of Medicine

SOUTH KOREA

View details

Dong M. Shin

Professor

Emory University

UNITED STATES

View details

Mukesh Kumar

Assistant Professor

University of Georgia

UNITED STATES

View details

Rabindra Tirouvanziam

Emory University School of Medicine

UNITED STATES

View details

Haley Huang

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ramireddy Bommireddy

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Chemoprevention of Head and Neck Cancer: A Review of Current Approaches and Future Perspectives

Tumor-Intrinsic Enhancer of Zeste Homolog 2 Controls Immune Cell Infiltration, Tumor Growth, and Lung Metastasis in a Triple-Negative Breast Cancer Model

Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses

Dendritic cells pulsed with cytokine-adjuvanted tumor membrane vesicles inhibit tumor growth in her2-positive and triple negative breast cancer models

Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck Cancer

Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer

Collaborators (7)

SAng Moo Kang

Periasamy Selvaraj

Sanghoon Han

Dong M. Shin

Mukesh Kumar

Rabindra Tirouvanziam

Haley Huang

Make your next move.